Atlas Trials

T790M Plasma Testing Methodology Comparison and Clinical Validation

Clinical trial NCT02997501 · COMPLETED

Trial details

NCT number
NCT02997501
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lung Cancer
Start date
2016-12-23
Primary completion
2018-10-24
Enrollment
256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.